miR-124-3p Combined with ANGPTL2 Has High Diagnostic Values for Obese and Nonobese Polycystic Ovary Syndrome
Table 3
Relationship between the expression of miR-124-3p in serum and the clinicopathological features of obese and nonobese PCOS patients.
Parameters
PCOS-obese (N = 42)
PCOS-nonobese (N = 60)
Pearson r
Pearson r
General comparison
Age
−0.084
0.597
−0.0292
0.8248
BMI
0.0525
0.7411
0.0861
0.513
Ferriman–Gallwey score
−0.3935
0.0099
−0.4104
0.0011
Lipid metabolism index
TC
−0.0758
0.6333
−0.0312
0.8129
TG
−0.0768
0.6288
−0.0308
0.8155
Glucose metabolism index
HOMA-IR
−0.267
0.0874
−0.148
0.259
FBG
−0.0769
0.6285
0.0322
0.8072
FINS
−0.3633
0.018
−0.2541
0.0501
Sex hormone levels
T
−0.4586
0.0023
−0.3685
0.0038
E2
−0.0753
0.6354
−0.03
0.8202
PRL
0.6254
<0.0001
0.6664
<0.0001
LH
−0.0755
0.6346
−0.0299
0.8204
FSH
0.2612
0.0947
0.0421
0.7492
LH/FSH
−0.2115
0.1787
0.0045
0.9729
Note. Pearson correlation coefficient was used to analyze the data. BMI = body mass index; TC = total cholesterol; TG = total triglyceride; HOMA-IR = HOMA insulin resistance; FBG = fasting blood glucose; FINS = fasting insulin; T = testosterone; E2 = estradiol; PRL = prolactin; LH = luteinizing hormone; FSH = follicle-stimulating hormone.
